• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

单一家系中 parkin 基因突变的表型变异性。

Phenotypic variability of parkin mutations in single kindred.

机构信息

Department of Neurogenetics, Kolling Institute of Medical Research, Royal North Shore Hospital and The University of Sydney, St. Leonards, New South Wales, Australia.

出版信息

Mov Disord. 2012 Sep 1;27(10):1299-303. doi: 10.1002/mds.25041. Epub 2012 Jul 17.

DOI:10.1002/mds.25041
PMID:22807239
Abstract

BACKGROUND

Mutations in parkin have been associated with autosomal recessive early-onset Parkinson's disease (PD). Here, we report on unusual phenotypic variability within a family with mutations in parkin.

METHODS

The proband and her parents were clinically assessed. Mutation analysis was performed using genomic DNA and complementary DNA. The protein expression of Parkin and Mitofusin 2 was examined by western blotting.

RESULTS

The proband was a compound heterozygote with no detectable Parkin and presented with early-onset PD. The father, a single heterozygote with reduced expression of Parkin, had mild loss of arm swing. The mother, who had only very mild rigidity, was unexpectedly found to be a homozygote with no Parkin expression. The proband, but not the parents, met the Queen Square Brain Bank criteria for PD. Parkin-dependent ubiquitination of Mitofusin 2 was impaired in the mother and the proband.

CONCLUSION

We report the first case of a homozygous mutation carrier in parkin who had no functional protein and only mild signs of parkinsonism in her seventh decade, whereas her daughter developed typical early-onset PD. This family demonstrates phenotypic variability in parkin-related parkinsonism. © 2012 Movement Disorder Society.

摘要

背景

Parkin 基因突变与常染色体隐性早发性帕金森病(PD)有关。在这里,我们报告了一个携带 Parkin 基因突变的家族中出现的不寻常表型变异性。

方法

对先证者及其父母进行临床评估。使用基因组 DNA 和互补 DNA 进行突变分析。通过 Western blot 检查 Parkin 和 Mitofusin 2 的蛋白表达。

结果

先证者是复合杂合子,Parkin 无法检测到,表现为早发性 PD。父亲是一个单杂合子,Parkin 表达减少,手臂摆动轻度丧失。母亲只有非常轻微的僵硬,出乎意料的是,她是一个没有 Parkin 表达的纯合子。先证者,但不是父母,符合 Queen Square Brain Bank 的 PD 标准。Parkin 依赖性 Mitofusin 2 的泛素化在母亲和先证者中受到损害。

结论

我们报告了首例 Parkin 纯合子突变携带者的病例,她在 70 多岁时没有功能性蛋白,只有轻微的帕金森症状,而她的女儿则发展为典型的早发性 PD。这个家族表现出与 Parkin 相关的帕金森病的表型变异性。© 2012 运动障碍学会。

相似文献

1
Phenotypic variability of parkin mutations in single kindred.单一家系中 parkin 基因突变的表型变异性。
Mov Disord. 2012 Sep 1;27(10):1299-303. doi: 10.1002/mds.25041. Epub 2012 Jul 17.
2
Lewy body Parkinson's disease in a large pedigree with 77 Parkin mutation carriers.一个有77名帕金基因突变携带者的大家族中的路易体帕金森病。
Ann Neurol. 2005 Sep;58(3):411-22. doi: 10.1002/ana.20587.
3
Early-onset Parkinson's disease caused by a novel parkin mutation in a genetic isolate from north-eastern Brazil.巴西东北部一个遗传隔离群体中由新型帕金基因突变引起的早发性帕金森病。
Neurogenetics. 2006 Mar;7(1):13-9. doi: 10.1007/s10048-005-0017-x. Epub 2005 Nov 22.
4
Marked variation in clinical presentation and age of onset in a family with a heterozygous parkin mutation.一个携带杂合性帕金基因突变的家族中,临床表现和发病年龄存在显著差异。
Mov Disord. 2003 Jul;18(7):758-63. doi: 10.1002/mds.10432.
5
[Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].帕金森病的病因与发病机制:从线粒体功能障碍到家族性帕金森病
Rinsho Shinkeigaku. 2004 Apr-May;44(4-5):241-62.
6
Parkinson's disease in Ireland: clinical presentation and genetic heterogeneity in patients with parkin mutations.爱尔兰的帕金森病:帕金森基因突变患者的临床表现与基因异质性
Mov Disord. 2004 Jun;19(6):677-81. doi: 10.1002/mds.10703.
7
Lewy bodies and parkinsonism in families with parkin mutations.携带帕金基因突变的家族中的路易小体与帕金森症
Ann Neurol. 2001 Sep;50(3):293-300. doi: 10.1002/ana.1132.
8
A multidisciplinary study of patients with early-onset PD with and without parkin mutations.一项针对有和没有帕金基因突变的早发性帕金森病患者的多学科研究。
Neurology. 2009 Jan 13;72(2):110-6. doi: 10.1212/01.wnl.0000327098.86861.d4. Epub 2008 Nov 5.
9
Differentiating symptomatic Parkin mutations carriers from patients with idiopathic Parkinson's disease: contribution of automated segmentation neuroimaging method.从有症状的 Parkin 突变携带者与特发性帕金森病患者中进行区分:自动化分割神经影像学方法的贡献。
Parkinsonism Relat Disord. 2012 Jun;18(5):562-6. doi: 10.1016/j.parkreldis.2012.02.017. Epub 2012 Mar 24.
10
Heterozygous parkin point mutations are as common in control subjects as in Parkinson's patients.杂合型帕金蛋白点突变在对照受试者和帕金森病患者中同样常见。
Ann Neurol. 2007 Jan;61(1):47-54. doi: 10.1002/ana.21039.

引用本文的文献

1
Cognitive Decline in Parkinsonism: From Clinical Phenotypes to the Genetic Background.帕金森病中的认知衰退:从临床表型到遗传背景
Biomedicines. 2025 Jul 2;13(7):1624. doi: 10.3390/biomedicines13071624.
2
Mitochondrial Damage and Autophagy Dysregulation in Alzheimer's Disease: Mechanisms and Therapeutic Opportunities.阿尔茨海默病中的线粒体损伤与自噬失调:机制与治疗机遇
Neurochem Res. 2025 Jul 28;50(4):251. doi: 10.1007/s11064-025-04490-z.
3
Mitophagy in Cell Death Regulation: Insights into Mechanisms and Disease Implications.
细胞死亡调控中的自噬作用:对机制和疾病影响的深入了解。
Biomolecules. 2024 Oct 9;14(10):1270. doi: 10.3390/biom14101270.
4
Protein Translation in the Pathogenesis of Parkinson's Disease.帕金森病发病机制中的蛋白质翻译。
Int J Mol Sci. 2024 Feb 18;25(4):2393. doi: 10.3390/ijms25042393.
5
The mitophagy pathway and its implications in human diseases.自噬途径及其在人类疾病中的意义。
Signal Transduct Target Ther. 2023 Aug 16;8(1):304. doi: 10.1038/s41392-023-01503-7.
6
Two Different Compound Heterozygous Variants Combinations in the Same Family.同一家族中的两种不同复合杂合变异组合
Mov Disord Clin Pract. 2023 Mar 20;10(5):845-847. doi: 10.1002/mdc3.13725. eCollection 2023 May.
7
Heterozygous PRKN mutations are common but do not increase the risk of Parkinson's disease.杂合性 PRKN 突变很常见,但不会增加帕金森病的风险。
Brain. 2022 Jun 30;145(6):2077-2091. doi: 10.1093/brain/awab456.
8
Therapeutic targeting of mitophagy in Parkinson's disease.治疗帕金森病中的线粒体自噬靶向治疗。
Biochem Soc Trans. 2022 Apr 29;50(2):783-797. doi: 10.1042/BST20211107.
9
Targeting Mitochondrial Impairment in Parkinson's Disease: Challenges and Opportunities.针对帕金森病中线粒体损伤:挑战与机遇
Front Cell Dev Biol. 2021 Jan 5;8:615461. doi: 10.3389/fcell.2020.615461. eCollection 2020.
10
Evolving and Expanding the Roles of Mitophagy as a Homeostatic and Pathogenic Process.作为一种动态平衡和致病过程,细胞自噬的作用在不断发展和扩展。
Physiol Rev. 2019 Jan 1;99(1):853-892. doi: 10.1152/physrev.00005.2018.